In South Africa, Success Against H.I.V. Offers Hopenews2022-01-11T14:59:11+00:00January 11th, 2022|The New York Times|
Covid Treatments Including Paxlovid Are Rationed as Cases Spikenews2022-01-06T22:11:24+00:00January 6th, 2022|The New York Times|
German Start-Ups Lay the Groundwork for a Marijuana Bonanzanews2022-01-05T19:51:30+00:00January 5th, 2022|The New York Times|
Biden Administration Doubles Order of Pfizer’s Covid Pillnews2022-01-05T00:40:34+00:00January 5th, 2022|The New York Times|
‘We May Need Even More’: Biden Doubles Pfizer’s Covid Pills Ordernews2022-01-05T00:24:37+00:00January 5th, 2022|The New York Times|
Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decisionnews2021-12-31T21:39:22+00:00December 31st, 2021|The New York Times|
F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boostersnews2021-12-31T02:43:34+00:00December 31st, 2021|The New York Times|
Teva Pharmaceuticals Found Liable in Landmark Opioid Trialnews2021-12-30T23:06:33+00:00December 30th, 2021|The New York Times|
J. & J. Booster Protects Against Severe Omicron, Study Saysnews2021-12-30T10:45:18+00:00December 30th, 2021|The New York Times|
Una alternativa a las gafas: gotas para los ojosnews2021-12-28T11:00:07+00:00December 28th, 2021|The New York Times|
